LEUKEMIA 360 will be held on 13 November 2024 at the Centre de Conférence Pierre Mendès France organised bu Carnot OPALE.

Carnot I2C, STAR and 3BCAR are joining forces for the 10th COSMETIC 360, the world innovation trade fair for the perfume and cosmetics industry, to be held in Paris on 16 and 17 October 2024.

Carnot Chimie Balard Cirimat, Icéel, Ingénierie@Lyon, M.I.N.ES, MICA, are taking part in LuxePack 2024 on the 30th September to 2nd October 2024 on a joint stand. 

Carnot CEA List and Thales announce the signature of their new partnership in the field of generative artificial intelligence (AI). Gathered within cortAIx, Thales' AI accelerator for mission-critical systems, the Group's AI research teams will collaborate with those of CEA List to provide sovereign, controlled and trusted AI solutions.

As they get older, the elderly are often forced to give up owning a pet, despite the benefits of such a relationship. What if technology could help preserve this precious bond? This could potentially slow down the loss of autonomy.  This is the subject of Hazar Zilelioglu's thesis, which brings together academic and industrial partners, with the support of Carnot TSN.

Paris (France), April 25, 2024 – PEP-Therapy, a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology, and Institut Curie, France’s leading cancer center, today announced the dosing of the first patients in a Phase Ib clinical trial evaluating PEP-Therapy’s lead candidate, PEP-010, based on highly encouraging Phase Ia results. This second part ot the Phase I study is evaluating PEP-010 in combination with chemotherapy (paclitaxel or gemcitabine), in advanced or metastatic ovarian cancer (OC) and in metastatic pancreatic ductal adenocarcinoma (PDAC), two indications with high unmet medical need.